Skip to main content

Table 1 Characteristics of the study participants according to the tertiles of serum concentration of prolactin at baseline and last follow-up

From: The effects of different physiologic concentrations of prolactin in association with reproductive hormones on the incidence of type 2 diabetes mellitus in men: Tehran Lipid and Glucose Study

Variables

Serum PRL concentration

Comparison

 

Baseline

Last follow-up*

P-value¥

P-value£

Tertile 1

(N = 223)

Tertile 2

(N = 222)

Tertile 3

(N = 207)

Tertile 1

(N = 223)

Tertile 2

(N = 222)

Tertile 3

(N = 207)

Age (year)a

44.3 (10.4)

44.0 (11.3)

43.4 (12)

59.5 (10)

59.5 (10.8)

58.9 (11.4)

0.7

0.8

BMI (kg/m2)a

25.4 (3.7)

26.0 (4.1)

26 (4.2)

27.2 (4.2)

27.4 (4.6)

28.0 (4.5)

0.2

0.1

Marital status (married), n (%)

213 (95.5)

213 (95.9)

192 (92.7)

210 (94.2)

212 (95.5)

200 (96.6)

0.3

0.5

Education (upper diploma), n (%)

132 (59.2)

117 (52.7)

116 (56)

150 (67.3)

117 (52.7)

128 (61.8)

0.4

0.1

Family history of diabetes, n (%)

56 (25.1)

60 (27.0)

62 (30)

56 (25.1)

60 (27.0)

62 (30)

0.5

0.5

Smoking status (ever), n (%)

112 (50.2)

91 (41.0)

84 (40.6)

119 (53.4)

95 (42.8)

89 (43.0)

0.07

0.3

Physical activity (appropriate), n (%)

44 (19.7)

52 (23.4)

35 (16.9)

95 (42.8)

97 (43.7)

82 (39.6)

0.2

0.7

WC (cm)a

87.5 (10)

88.3 (11.5)

88.9 (11)

96.6 (10.8)

96.9 (11.4)

98.2 (11.1)

0.4

0.3

HC (cm)a

95.5 (6.6)

96.9 (7.1)

96.6 (7.8)

97.9 (7.4)

98.8 (7.9)

99.4 (8.5)

0.1

0.1

WHRa

0.91 (0.06)

0.91 (0.07)

0.92 (0.06)

0.98 (0.06)

0.98 (0.05)

0.99 (0.05)

0.3

0.3

WrC (cm)a

17.6 (0.9)

17.7 (0.9)

17.8 (1)

17.7 (1.0)

17.8 (1.0)

17.9 (1.1)

0.6

0.3

SBP (mmHG)a

118.7 (19.2)

118.8 (19.4)

119.9 (16)

122.7 (20.9)

122.9 (19.0)

121.9 (15.6)

0.8

0.9

DBP (mmHG)a

78.2 (11.2)

76.9 (9.8)

78.5 (11)

79.4 (11.2)

78.6 (10.2)

79.8 (10.8)

0.2

0.5

Total cholesterol (mg/dl)a

205.9 (35.6)

205.2 (40.2)

210 (38)

190.9 (37)

188.3 (36.3)

195.4 (42.0)

0.4

0.1

TG (mg/dl)b

149 (103 − 203)

157 (109 − 231)

154 (111 − 207)

135 (97 − 185)

138.5 (103 − 198)

138 (99 − 196)

0.3

0.5

LDL (mg/dl)a

132.5 (30.1)

130.9 (35.8)

136.5 (34.8)

117.7 (31.6)

113.5 (31)

121.1 (36)

0.2

0.06

HDL (mg/dl)a

39.7 (10.5)

38.2 (9.2)

38.7 (9.3)

43.6 (10.4)

42.8 (10.4)

43.2 (9.8)

0.2

0.7

FPG (mg/dl)a

90.6 (9.3)

90.0 (9.6)

90.9 (8.5)

101.7 (25)

101.2 (22)

101.6 (22.5)

0.6

0.9

2-h OGTT glucose (mg/dl)a

100.3 (29.2)

96.7 (29.7)

96.7 (28)

130.8 (57.8)

133.3 (58.4)

130 (51.9)

0.2

0.8

LH (IU/l)b

3.9 (2.7 − 5.5)13

4.0 (3.0 − 5.1)23

4.5 (3.5 − 5.8)

-

-

-

0.003

-

FSH (IU/l)b

5.4 (3.9 − 7.8)

5.1 (3.5 − 7.8)

5.1 (3.4 − 8)

-

-

-

0.9

-

LH/FSH ratiob

0.75 (0.52 − 1)13

0.75 (0.53 − 0.97)23

0.77 (0.59 − 1.2)

-

-

-

0.04

-

AMH (ng/dl) b

5.7 (3.5 − 8.3)

6.25 (3.6 − 9.4)

6 (3.5 − 8.6)

-

-

-

0.4

-

Testosterone (ng/dl)b

4.7 (3.8 − 5.5)

4.9 (4.1 − 5.6)

4.8 (4 − 5.6)

-

-

-

0.3

-

DM, n (%)†

-

-

-

35 (15.7)

43 (19.4)

30 (14.5)

-

0.4

Age at DM onset (year)b

-

-

-

58 (51 − 67)

56 (51 − 69)

53.5 (47 − 63)

-

0.2

  1. Abbreviations: PRL Prolactin, BMI Body mass index, WC Waist circumference, HC Hip circumference, WHR Waist-to-hip ratio, WrC Wrist circumference, SBP Systolic blood pressure, DBP Diastolic blood pressure, TG Triglyceride, LDL Low-density lipoprotein cholesterol, HDL High-density lipoprotein cholesterol, FPG Fasting plasma glucose, OGTT Oral glucose tolerance test, LH Luteinizing hormone, FSH Follicle stimulating hormone, AMH Anti-mullerian hormone, DM Diabetes mellitus
  2. Data are presented as mean (SD) a, median (IQR) b, or number (%) as appropriate. ANOVA test, Kruskal–Wallis test, or χ2 test were used as appropriate
  3. *Last follow up was considered a visit at which participants experienced either a DM outcome or the last follow-up which they have been censored
  4. ¥For the comparison of baseline characteristics between tertiles of serum PRL concentration; £ For the comparison of last follow up characteristics between tertiles of serum PRL concentration; 13 Statistically significant result for comparison between tertiles 1 and 3 of serum PRL concentration (p < 0.01); 23 Statistically significant result for comparison between tertiles 2 and 3 of serum PRL concentration (p < 0.01)
  5. †The incidence rate of DM and the age at DM onset were not reported at baseline, as the participants with a previous diagnosis of DM were initially excluded from the study